- cafead   Sep 11, 2024 at 11:32: PM
via Roche is holding out hopes that its injectable obesity prospect could eventually demonstrate 25% weight loss in late-stage trials, the pharma’s head of metabolism R&D has told Fierce Biotech.
article source
article source